Recall of Catheter for Accu-chek External Insulin Pump FlexLink Plus

According to L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), this recall involved a device in France that was produced by Roche Diagnostics.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Date
    2011-03-09
  • Event Country
  • Event Source
    ANSM
  • Event Source URL
  • Notes / Alerts
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Extra notes in the data
  • Action
    In agreement with Afssaps, Roche Diagnostics, on 04/03/2011, informed users of Accu-chek FlexLink Plus external insulin pump catheters for withdrawal and discontinuation of this product. concerned, in France, have received one of the following letters:. health providers (09/03/2011) (668 ko patients (09/03/2011) (661 kb prescribers (09/03/2011) (668 ko hospitals (09/03/2011) (671 ko)

Device

Manufacturer